Confluent (NASDAQ: CFLT) CEO reports Class A stock sales and option exercises

Rhea-AI Filing Summary

Confluent, Inc.'s chief executive officer and director reported exercising stock options for Class B common stock, converting those shares into Class A common stock and then selling the resulting Class A shares. On 12/12/2025, he converted 506,000 shares of Class B into Class A and sold 506,000 Class A shares at prices ranging from $30.02 to $30.10. On 12/15/2025, he converted 232,500 shares of Class B into Class A and sold 232,500 Class A shares at prices between $30.05 and $30.14.

After these transactions, he directly owned 339,367 shares of Class A common stock. The filing also shows additional positions related to Class A common stock held indirectly through family trusts, including 149,984 shares in a 2018 revocable trust and 1,000,000-share positions in each of two 2019 irrevocable trusts. The 232,500-share sale on 12/15/2025 was made under a Rule 10b5-1 trading plan adopted on August 15, 2024.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kreps Edward Jay

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/12/2025		C		506,000	A	(1)	845,367	D
Class A Common Stock	12/12/2025		S		506,000	D	$30.04(2)	339,367	D
Class A Common Stock	12/15/2025		C		232,500	A	(1)	571,867	D
Class A Common Stock	12/15/2025		S		232,500(3)	D	$30.1(4)	339,367	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.24	12/12/2025		M			506,000	(5)	10/21/2028	Class B Common Stock	506,000	$0	1,219,153	D
Class B Common Stock	(1)	12/12/2025		M		506,000		(1)	(1)	Class A Common Stock	506,000	$0	14,988,500	D
Class B Common Stock	(1)	12/12/2025		C			506,000	(1)	(1)	Class A Common Stock	506,000	$0	14,482,500	D
Class B Common Stock	(1)	12/15/2025		C			232,500	(1)	(1)	Class A Common Stock	232,500	$0	14,250,000	D
Class B Common Stock	(1)							(1)	(1)	Class A Common Stock	149,984		149,984	I	See footnote(6)
Class B Common Stock	(1)							(1)	(1)	Class A Common Stock	1,000,000		1,000,000	I	See footnote(7)
Class B Common Stock	(1)							(1)	(1)	Class A Common Stock	1,000,000		1,000,000	I	See footnote(8)

Explanation of Responses:

1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.

2. The shares were sold at prices ranging from $30.02 to $30.10. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024.

4. The shares were sold at prices ranging from $30.05 to $30.14. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. Fully vested.

6. The shares are held by The Edward J. Kreps and Jamaica H. Kreps 2018 Revocable Trust.

7. The shares are held by the GST Exempt Trust under The Kreps Family 2019 Irrevocable Trust under agreement dated 9/26/2019.

8. The shares are held by the GST Exempt Trust under The Kreps Family 2019 Irrevocable Trust under agreement dated 9/26/2019.

	/s/ Weilyn Wood, Attorney-in-Fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Confluent (CFLT) report in this Form 4?

The filing shows the chief executive officer and director exercised stock options for Class B common stock, converted those shares into Class A common stock, and sold the resulting Class A shares in open-market transactions on 12/12/2025 and 12/15/2025.

How many Confluent (CFLT) shares were sold and at what prices?

On 12/12/2025, 506,000 Class A shares were sold at prices ranging from $30.02 to $30.10. On 12/15/2025, 232,500 Class A shares were sold at prices ranging from $30.05 to $30.14.

How many Confluent (CFLT) Class A shares does the insider hold after these trades?

Following the reported transactions, the reporting person directly beneficially owned 339,367 shares of Confluent Class A common stock.

Were the Confluent (CFLT) share sales made under a Rule 10b5-1 plan?

Yes. The sale of 232,500 Class A shares on 12/15/2025 was made pursuant to a Rule 10b5-1 trading plan that was adopted on August 15, 2024, as disclosed in the footnotes.

Does the Confluent (CFLT) insider still have additional holdings through trusts?

Yes. The filing notes Class A shares held through family trusts, including 149,984 shares in a 2018 revocable trust and 1,000,000 shares in each of two 2019 irrevocable trusts, in addition to substantial Class B common stock positions.